NL-OMON32887已完成4 期
Development of cellular immune response after infant pneumococcal conjugate vaccinations - Pneumococcal cellular immune response
ederlands Vaccin Instituut0 个研究点目标入组 100 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 2 至 11（—）
入选标准
- •Healthy children 11 or 24 months of age. The parents are willing and able to let their child participate in the trial according to the described procedures, with a a signed informed consent
- •The children have received (24 months old children) or will receive the Prevenar® vaccinations according to the 3+1 schedule as part of the Dutch NIP
排除标准
- •Previous vaccinations with Prevenar using a schedule that differs from the National Immunisation Program (3+1 schedule) or with other pneumoccocal vaccines.
- •Presence of a serious disease that can interfere with the results of the study
研究者
相似试验
进行中（未招募）
1 期
Development of cellular immune response after infant pneumococcal conjugate vaccinations - Pneumococcal cellular immune responseCellular immune response(long term memory) after following the infant immunisation programme with a pneumococcal conjugate vaccine (Prevenar).EUCTR2008-004489-23-NLetherlands Vaccine Institute100
已完成
不适用
Development of cellular immune response after infant pneumococcal conjugate vaccinations.NL-OMON26266etherlands Vaccine Institute100
已完成
不适用
Humoral and cellular immune response after influenza vaccination in patients with postcancer fatigue and in patients with the chronic fatigue syndrome.Chronisch vermoeidheidssyndroomFatiguetiredness10027655NL-OMON35062niversitair Medisch Centrum Sint Radboud80
已完成
Unknown
Investigation of cell mediated immune response induced by varicella vaccinePrevention of herpes zosterJPRN-jRCT1080223477The Research Foundation for Microbial Diseases of Osaka University80
进行中（未招募）
1 期
Immuneresponse and clinical efficacy after SARS-CoV-2 Vaccination in immunodefficient patients or those undergoing immunosuppresive therapy (COVID-19)EUCTR2021-000291-11-ATMedical University of Vienna3,000